A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4245 (2006.01) A61K 31/00 (2006.01) A61K 31/16 (2006.01) A61K 31/18 (2006.01) A61K 31/185 (2006.01) A61K 31/195 (2006.01) A61K 31/197 (2006.01) A61K 31/198 (2006.01) A61K 31/20 (2006.01) A61K 31/401 (2006.01) A61K 31/4015 (2006.01) A61K 31/41 (2006.01) A61K 31/433 (2006.01) A61K 31/662 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2509600
The invention relates to a method of treating central nervous system disorders and other disorders by administering an alpha2delta ligand such as, for example, a compound of the formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 is hydrogen or straight or branched lower alkyl, and n is an integer of from 4 to 6.
La présente invention concerne une méthode de traitement des troubles du système nerveux central et d'autres troubles, ladite méthode consistant à administrer un ligand alpha2delta tel que, par exemple, un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de ce dernier. Dans la formule (I), R¿1? représente hydrogène ou alkyle inférieur linéaire ou ramifié et n représente un entier compris entre 4 et 6. Formule (I)
Dooley David James
Taylor Charles Price Jr.
Thorpe Andrew John
Wang Fong
Wustrow David Juergen
Smart & Biggar
Warner-Lambert Company Llc
LandOfFree
Pharmaceutical uses for alpha2delta ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical uses for alpha2delta ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical uses for alpha2delta ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1751784